Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy
β Scribed by Pramod C. Sogani; Minoo R. Vagaiwala; Willet F. Whitmore Jr.
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 699 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Elevated serum chromogranin A (CgA) levels have been detected in patients with prostate cancer who have developed resistance to hormonal therapy. We would like to reexamine these cases by using serial specimens to determine whether such elevated levels are also detectable in prostate cancer patients
## Abstract ## BACKGROUND The purpose of this study was to compare predictive factors for the efficacy of androgen deprivation therapy (ADT) in men with hormoneβsensitive prostate cancer (HSPC) either with (M+) or without (Mβ) metastases. ## METHODS A cohort of prostate cancer patients was ident